Article info

PACLITAXEL/CARBOPLATIN (TC) VS PACLITAXEL/CARBOPLATIN FOLLOWED BY TOPOTECAN (TC-TOP) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB–IV. INTERIM RESULTS OF A GYNECOLOGIC CANCER INTERGROUP PHASE III TRIAL OF THE AGO OVARIAN CANCER STUDY GROUP AND GINECO

Authors

Citation

Stahle A, Schroder W, Meier W, et al
PACLITAXEL/CARBOPLATIN (TC) VS PACLITAXEL/CARBOPLATIN FOLLOWED BY TOPOTECAN (TC-TOP) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB–IV. INTERIM RESULTS OF A GYNECOLOGIC CANCER INTERGROUP PHASE III TRIAL OF THE AGO OVARIAN CANCER STUDY GROUP AND GINECO
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.